Ropivacaine
- Generic Name
- Ropivacaine
- Brand Names
- Naropin
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26N2O
- CAS Number
- 84057-95-4
- Unique Ingredient Identifier
- 7IO5LYA57N
- Background
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
- Indication
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
- Associated Conditions
- Acute Pain, Postoperative pain
- Associated Therapies
- Surgical anesthesia therapy
Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome
- Conditions
- Interventions
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- Centre Hospitalier Universitaire de la Réunion
- Registration Number
- NCT02857465
Use of Regional Anesthesia in Hip Arthroscopy
- Conditions
- Interventions
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 70
- Registration Number
- NCT02851888
- Locations
- 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Jacques E. Chelly
- Target Recruit Count
- 68
- Registration Number
- NCT02849678
- Locations
- 🇺🇸
UPMC Presbyterian Shadyside, Pittsburgh, Pennsylvania, United States
Effects of Dexmedetomidine as Adjunct to Pudendal Block for Pediatric Penile Surgery
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 40
- Registration Number
- NCT02848157
- Locations
- 🇰🇷
Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Ajou University School of Medicine
- Target Recruit Count
- 84
- Registration Number
- NCT02848287
Ischemic Pain Control With Analgesic Methods Clinical Trial
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT02841488
The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability
- First Posted Date
- 2016-07-12
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- Nordsjaellands Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT02829697
- Locations
- 🇩🇰
Claus Behrend Christiansen, Hillerød, Denmark
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
- First Posted Date
- 2016-07-12
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Duke University
- Target Recruit Count
- 84
- Registration Number
- NCT02829944
- Locations
- 🇺🇸
Duke University Hospital, Durham, North Carolina, United States
Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section
- Conditions
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Jena University Hospital
- Registration Number
- NCT02828059
Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- University Hospital, Lille
- Target Recruit Count
- 184
- Registration Number
- NCT02821169
- Locations
- 🇫🇷
CHRU, Hôpital Claude Huriez, Lille, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.